Statistical analysis:
Continuous variables are presented as mean ± SD or median (interquartile
range). Categorical variables are presented as percentages. The t-test
was used for normally distributed data, the Mann–Whitney U test was
used for non-normally distributed data, and the χ2-test was used for
categorical variables. Multivariate logistic regression analyses were
conducted to assess the anatomical characteristics of the PFO concerning
the incidence rate of CS. Odds ratios are reported with 95% confidence
intervals. Independent risk factors for CS were determined based on the
results of multivariate analysis. Receiver operating characteristic
(ROC) curves and area under the ROC curves (AUC) were studied and
calculated. For each participant, demographic data and clinical data
were analyzed using SPSS 27.0 software, with statistical significance
defined as P < 0.05.
Results:
1.Study cohort
This study was an observational study. In total, 134 patients were
included (male patients n=55, 40.7%), with an average age of years
(38±11.2) (Table 1). There were 50 patients with severe RLS
(right-to-left shunts) and 84 patients with mild-to-moderate RLS
(right-to-left shunts). In the massive shunt group, cerebral infarction
accounted for 39.6% and migraine accounted for 64%.
2. Severe RLS vs. mild-to-moderate RLS
There was no significant difference in terms of gender (42% vs.
38.8%,p=0.383), age (39.76±11.38 vs. 37.98±11.10, p=0.373), previous
hypertension (18% vs. 14.1%,p=0.625), diabetes (6% vs. 2.4%,
p=0.359), smoking (16% vs. 15.3%, p=1.000), the incidence of cerebral
infarction (39.6 vs. 38.5, p=1.000 ), migraine (64% vs. 63.5%,
p=1.000), the presence of the Eustachian valve or a Chiari’s network
(10% vs. 5.9%, p=0.499), left funnelform (28% vs. 31.8% p=0.701),
right funnelform (26.0% vs. 21.2%, p=0.532), the length of the tunnel
(10.2±3.7 vs. 9.7±4.6, P=0.585), the thickness of the primary septum and
the secondary septum (1.2±0.3 vs. 1.3±0.4, 3.7±1.0 vs. 3.5±1.0, P=0.172,
P=0.369), and the RoPE score and the multiple exits of the tunnel of LA
(6.6±1.5 vs. 6.8±1.7, 28% vs. 27.1%, P=0.463, P=1.000). However the
long diameter of FO (1.74±0.3 vs. 1.60±0.4, P=0.039), short diameter of
FO (1.12±0.3 vs. 1.00±0.3, P=0.036), perimeter of FO (4.62±0.7 vs.
4.22±1.0, P=0.026) and area (1.80±0.8 vs. 1.35±0.8, P=0.05) of FO were
significantly larger in the severe RLS group.
There were 49 cases of cerebral infarction, 69 cases of migraine, and 16
cases of dizziness. In table 2, compared with the migraine group, the
cerebral infarction group had a higher proportion of male participants
(59.2% vs. 30.25%, p=0.002), a higher age (41.9±8.6 vs. 36.8±12.1,
P=0.01), a larger proportion of hypertension (26.5% vs. 9.3% P=0.012),
a larger number of smokers (30.6% vs. 3.0%, P<0.001), a larger
proportion of Eustachian valve or a Chiari’s network (14.3% vs. 3.5%,
P=0.036), a larger proportion of left funnelform (55.1% vs. 16.3%,
P<0.001), a longer length of the tunnel (13.4±4.4 vs. 7.8±2.5,
P<0.001), a smaller angle (16.4±3.4 vs. 20.3±7.7, P=0.001), a
higher proportion of vascular stenosis in the brain and neck (8.2% vs.
0%, 53.1% vs. 20.9%, P=0.016, P=0.001), a higher RoPE score (7.6±1.1
vs. 6.3±1.4, P<0.001), and a higher proportion of multiple exits
of the tunnel of LA (46.9% vs. 14.3%, P<0.001). However, there
was no significant difference in shunt between the two groups (36.7%
vs. 37.6, P=0.969).
3.Multivariate regression analysis showed that male
(HR:4.026,95%CI:0.883~18.361, P=0.072), age
(HR:1.076,95%CI:1.002~1.155, P=0.045), left funnelform
(HR:7.299, 95%CI:1.585~33.618, P=0.011), long tunnel
(HR:1.843, 95% CI: 1.404~2.418, P<0.001) and
multiple exits of the tunnel of LA (HR: 8.544, 95% CI:
1.595~45.754, P=0.012) were positively associated with the
risk of cerebral infarction (Table 3).
4.The diagnostic performance of high-risk PFO was assessed by using
receiver operating characteristic (ROC) curves and the area under the
ROC curve analysis show in figure 9 and figure10. The cut-off value
calculated by ROC for the diagnosis of high-risk PFO was that the length
of the PFO tunnel was 10.4 mm (sensitivity was 90%, specificity was
87%). Left funnelform combined with multiple exits of left atrial
(sensitivity was 89%, specificity was 91%). The area under the curve
of PFO tunnel length VS left funnelform + multiple exits of left atrial
VS PoPE score (0.921 VS 0.932 VS 0.736) relative to the RoPE score was
statistically significant. The cut-off value calculated by ROC for the
diagnosis of high-risk PFO was that the length of the PFO tunnel was 12
mm and Left funnelform combined with multiple exits of left atrial
(sensitivity was 92%, specificity was 90%). The area under the curve
of combine index VS PoPE score (0.932 VS 0.736) relative to the RoPE
score was statistically significant.
Discussions:
PFO can serve as a conduit for paradoxical embolism, allowing venous
thrombi to enter the arterial circulation, avoiding filtration by the
lungs, and causing ischemic stroke. The anatomical structure of PFO
indicates that in addition to thrombi, it allows harmful circulatory
factors to circulate directly from veins to arteries [4]. There are
many theories about the mechanism of stroke in patients with PFO: 1)
Abnormal embolism, one type of venous thrombosis (also known as air,
fat, and infectious substances) enters the arterial circulation through
the PFO, avoiding the filtration of the lungs and leading to cerebral
embolism; and 2) due to various high-risk anatomical features, primary
thrombosis occurs in the PFO lumen.
PFO itself has been suspected as the site of thrombus formation [2,
16]. Consistent with previous studies, this study found that the
proportion of PFO long tunnel and the left funnelform was higher in CS.
The potential mechanisms underlying the link between PFO and migraine
[17] micro embolus-induced cortical spreading depression
(CSD)[18], the vasoactive substance hypothesis [19] and shared
genetic predisposition [20]. Migraine is a common and recurrent
disease, often confined to one side, manifested as paroxysmal pain. The
symptoms of migraine often include nausea, vomiting, dizziness,
photophobia and phonophobia [21]. Studies have shown that migraine
can lead to various neurological diseases, including stroke, cerebral
infarction, and long-term ischemia-reperfusion injury. Therefore,
migraine is considered to be the third most frequent chronic disabling
disease worldwide [22]. PFO-related right-to-left shunting allows
potentially vasoactive substances to bypass the lung, which may
aggravate cerebral injury [23]. 5-HT has been linked to the
pathogenesis of migraine [24]. This study found that severe
right-to-left shunt was relatively common among patients with severe
migraine and stroke. PFO and migraine are both prevalent and have highly
heterogeneous presentations. Their coincidence remains a debating issue,
but it is less likely a coincidental finding, since experimental
micro-embolism can depress cortical spreading [25].
C-TCD diagnosis of RLS mainly relies on the Valsalva maneuver. It is not
possible to stimulate right-to-left shunting using Faraday’s maneuver
under TEE; thus, we used abdominal compression to stimulate
right-to-left shunting. Our findings were highly consistent with the
results of the C-TCD stimulation test. The blood flow returning from the
vena cava to the right atrium increases and RAP instantly increases
after the release of abdominal pressure. When the right atrial pressure
increases and exceeds the left atrial pressure, PFO may re-open, and
microbubbles can be observed to enter the left atrium through the PFO
tunnel.
PFO is a dynamic and three-dimensional structure as it originates from
the embryonic septum primum and secondum. The structure of PFO is best
described as a dynamic tunnel (not just a “hole”) outlined by opposing
myocardial flaps remaining from the fetal septum primum and secondum,
which never fully fused to wall off the right atrium from the left
atrium. Since the IAS is a complex, dynamic, and 3D anatomic structure,
2D echocardiography cannot comprehensively evaluate it.
Current treatments of PFO include medical treatment utilizing
anticoagulants and/or antiplatelet agents, endovascular PFO closure by
meshed devices, or even surgical closure. Even “asymptomatic” PFO
leads to pulmonary gas exchange inefficiency. Endovascular PFO closure
improves exercise capacity and reduces exercise-induced hypoxemia. In
clinical settings, patients frequently report improved general exercise
tolerance and better vascular perfusion to the extremities after the
closure of PFO.
Conclusion
Even if a quarter of people have PFO, or asymptomatic PFO, but prone to
right to left PFO there is a risk of unexplained stroke. PFO with
high-risk features may lead to clinically significant and clinically
asymptomatic events. The evaluation of PFO dynamics using
three-dimensional combined two-dimensional echocardiography can help
better identify high-risk PFO.
Limitation:
Our study had some limitations as follows:
1. This was a single-center study.
2. Neurologically asymptomatic subjects who have a PFO on TEE would be
the ideal participants for the control or comparison group, but for this
study, we used patients with migraine as the control group.
3. The grade of RLS might be underestimated because it depends on the
degree of Valsalva maneuver.
Author contribution:
Li Wang: Data collation and analysis, methodology, writing the first
draft
Haibo Sun: Data collation and analysis
Han Shen: Project management, methodology, monitoring, writing, and
editing. All authors studied and approved the final manuscript.
Funding:
This study was specifically funded by The Bo Xi Youth Natural Science
Foundation (NO.BXQN2023016)
Acknowledgments:
We would like to thank all patients and researchers involved in this
study.
Conflict of interest
None
Competing interests
The authors have no known competing financial interests or personal
relationships that could affect the work reported in this paper.
Ethics approval
The Ethics Committee of The Affiliated Hospital of Soochow University
(No.235/2024) approved the protocol of this study.
Availability of data and materials
The research data is confidential.
References:
1. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent
foramen ovale during the first 10 decades of life: an autopsy study of
965 normal hearts . Mayo Clin Proc 1984, 59 (1):17-20.2.
Elgendy AY, Saver JL, Amin Z, Boudoulas KD, Carroll JD, Elgendy IY,
Grunwald IQ, Gertz ZM, Hijazi ZM, Horlick EM et al :Proposal for Updated Nomenclature and Classification of
Potential Causative Mechanism in Patent Foramen Ovale-Associated
Stroke . JAMA Neurol 2020, 77 (7):878-886.3. Lammers A,
Hager A, Eicken A, Lange R, Hauser M, Hess J: Need for closure
of secundum atrial septal defect in infancy . J Thorac Cardiovasc
Surg 2005, 129 (6):1353-1357.4. Ning M, Lo EH, Ning PC, Xu SY,
McMullin D, Demirjian Z, Inglessis I, Dec GW, Palacios I, Buonanno FS:The brain’s heart - therapeutic opportunities for patent foramen
ovale (PFO) and neurovascular disease . Pharmacol Ther 2013,139 (2):111-123.5. Calvert PA, Rana BS, Kydd AC, Shapiro LM:Patent foramen ovale: anatomy, outcomes, and closure . Nat
Rev Cardiol 2011, 8 (3):148-160.6. Silvestry FE, Cohen MS,
Armsby LB, Burkule NJ, Fleishman CE, Hijazi ZM, Lang RM, Rome JJ, Wang
Y: Guidelines for the Echocardiographic Assessment of Atrial
Septal Defect and Patent Foramen Ovale: From the American Society of
Echocardiography and Society for Cardiac Angiography and Interventions .J Am Soc Echocardiogr 2015, 28 (8):910-958.7. Schneider
B, Zienkiewicz T, Jansen V, Hofmann T, Noltenius H, Meinertz T:Diagnosis of patent foramen ovale by transesophageal
echocardiography and correlation with autopsy findings . Am J
Cardiol 1996, 77 (14):1202-1209.8. Nakayama R, Takaya Y, Akagi
T, Watanabe N, Ikeda M, Nakagawa K, Toh N, Ito H: Identification
of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke:
Development of a Scoring System . J Am Soc Echocardiogr 2019,32 (7):811-816.9. Lucà F, Pino PG, Parrini I, Di Fusco SA,
Ceravolo R, Madeo A, Leone A, La Mair M, Benedetto FA, Riccio C et
al : Patent Foramen Ovale and Cryptogenic Stroke: Integrated
Management . J Clin Med 2023, 12 (5).10. Pu H, Zhang Q,
Wu J, Zhang Y, Zhao Y, Li L: Assessment of the Characteristics
of Patent Foramen Ovale Associated with Cryptogenic Stroke . Curr
Med Imaging 2024.11. Akagi T: Transcatheter closure of patent
foramen ovale: Current evidence and future perspectives . J
Cardiol 2021, 77 (1):3-9.12. Pushparajah K, Miller OI, Simpson
JM: 3D echocardiography of the atrial septum: anatomical
features and landmarks for the echocardiographer . JACC Cardiovasc
Imaging 2010, 3 (9):981-984.13. The International
Classification of Headache Disorders: 2nd edition . Cephalalgia 2004, 24 Suppl 1 :9-160.14. Bernard S, Churchill TW, Namasivayam
M, Bertrand PB: Agitated Saline Contrast Echocardiography in the
Identification of Intra- and Extracardiac Shunts: Connecting the Dots .J Am Soc Echocardiogr 2020.15. Fan S, Nagai T, Luo H, Atar S,
Naqvi T, Birnbaum Y, Lee S, Siegel RJ: Superiority of the
combination of blood and agitated saline for routine contrast
enhancement . J Am Soc Echocardiogr 1999,12 (2):94-98.16. Yan C, Li H: Preliminary Investigation
of In situ Thrombus Within Patent Foramen Ovale in Patients With and
Without Stroke . Jama 2021, 325 (20):2116-2118.17. Cao W,
Shen Y, Zhong J, Chen Z, Wang N, Yang J: The Patent Foramen
Ovale and Migraine: Associated Mechanisms and Perspectives from MRI
Evidence . Brain Sci 2022, 12 (7).18. Ashina M, Hansen
JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA: Migraine
and the trigeminovascular system-40 years and counting . Lancet
Neurol 2019, 18 (8):795-804.19. Wilmshurst P, Nightingale S:The role of cardiac and pulmonary pathology in migraine: a
hypothesis . Headache 2006, 46 (3):429-434.20. Wilmshurst
PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL:Inheritance of persistent foramen ovale and atrial septal
defects and the relation to familial migraine with aura . Heart 2004, 90 (11):1315-1320.21. Ashina M, Terwindt GM, Al-Karagholi
MA, de Boer I, Lee MJ, Hay DL, Schulte LH, Hadjikhani N, Sinclair AJ,
Ashina H et al : Migraine: disease characterisation,
biomarkers, and precision medicine . Lancet 2021,397 (10283):1496-1504.22. Burch R: Preventive Migraine
Treatment . Continuum (Minneap Minn) 2021,27 (3):613-632.23. International Stroke Conference Oral
Presentations . Stroke 2011, 42 (3):e42-e110.24. Anthony
M, Hinterberger H, Lance JW: Plasma serotonin in migraine and
stress . Arch Neurol 1967, 16 (5):544-552.25. Tietjen GE,
Collins SA: Hypercoagulability and Migraine . Headache 2018, 58 (1):173-183.
Table 1: The characteristics of patients and PFO.
Note: Values are presented as mean±SD or n (%).
Abbreviation: PFO, patent foramen ovale. RoPe, risk of paradoxical
embolism. BMI, body mass index. FO, fossa ovale. RLS, right-to-left
shunts. LA, left atrium.
Table 2: Comparison of basic characteristics and echocardiographic
features between the cryptogenic group and the migraine group.
Note: Values are mean±SD or n (%).
Abbreviation: PFO, patent foramen ovale. RoPe, risk of paradoxical
embolism. BMI, body mass index. FO, fossa ovale. RLS, right-to-left
shunts. LA, left atrium. TCD, transcranial doppler. IVC, inferior vena
cava.
Table 3: Multivariate logistic regression analysis for the
echocardiographic characteristics of the cryptogenic group and the
migraine group.
Note:
Abbreviation: PFO, patent foramen ovale. LA, left atrium.
Figure 1: Fossa Ovalis and PFO.
Figure 2: The thickness of the primary septum and the thickness of the
secondary septum.
Figure 3: The height and length of the PFO tunnel.
Figure 4: Left funnelform and right funnelform.
Figure 5: The exit of the PFO tunnel by three-dimensional TEE.
Figure 6: Measurement of the oval fossa.
Figure 7: The presence of PFO was confirmed by actual visualization of
microbubbles passing through the separation between the septum primum
and septum secundum.
Figure 8: Measurement of IVC-PFO angle.
Figure 9. The diagnostic performance of high-risk PFO was assessed by
using receiver operating characteristic (ROC) curves
Figure 10. The combine index diagnostic performance of high-risk PFO was
assessed by using receiver operating characteristic (ROC) curves
Supplementary Figure: Trial flowchart.